Ad
QNRX Quote Trading Chart Quoin Pharmaceuticals Ltd.
home / stock / qnrx / qnrx quote
$4.78 Last:
1095.0% Change Percent:
$4.83 Open:
$0.40 Previous Close:
$5.09 High:
$4.7 Low:
787,141 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
QNRX Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-12 | 4.83 | 0.4 | 5.09 | 4.7 | 787,141 |
| 2022-08-11 | 4.93 | 0.4 | 5.68 | 4.69 | 2,279,545 |
| 2022-08-10 | 4.85 | 0.4 | 6.49 | 4.45 | 7,359,260 |
| 2022-08-09 | 5.75 | 0.4 | 5.8105 | 4.8 | 2,195,616 |
| 2022-08-08 | 6.03 | 0.4 | 6.5 | 5.48 | 5,326,312 |
| 2022-08-05 | 6.58 | 0.4 | 7.1 | 4.33 | 16,123,341 |
| 2022-08-04 | 18.77 | 0.4 | 22 | 11.68 | 11,511,074 |
| 2022-08-03 | 4.33 | 0.4 | 28.11 | 4.17 | 28,284,443 |
| 2022-08-02 | 6.78 | 0.4 | 7.33 | 4.11 | 4,591,800 |
| 2022-08-01 | 4.29 | 0.4 | 4.29 | 3.58 | 160,512 |
| 2022-07-29 | 0.3732 | 0.4 | 0.374 | 0.3313 | 508,574 |
| 2022-07-28 | 0.4 | 0.4 | 0.4002 | 0.36 | 574,576 |
| 2022-07-26 | 0.4134 | 0.4134 | 0.4299 | 0.38 | 267,734 |
| 2022-07-19 | 0.4009 | 0.4098 | 0.42 | 0.39 | 515,270 |
| 2022-07-18 | 0.42 | 0.415 | 0.4544 | 0.401 | 748,627 |
| 2022-07-15 | 0.46 | 0.41 | 0.4699 | 0.401 | 1,152,245 |
| 2022-07-14 | 0.49 | 0.4699 | 0.4999 | 0.45 | 402,942 |
| 2022-07-13 | 0.4469 | 0.4705 | 0.5099 | 0.4469 | 276,565 |
| 2022-07-12 | 0.49 | 0.4798 | 0.524 | 0.4422 | 481,941 |
| 2022-07-11 | 0.5201 | 0.52 | 0.53 | 0.5 | 456,576 |
Quoin Pharmaceuticals Ltd. Company Name:
QNRX Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
ASHBURN, Va., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its second quarter 2022 financial re...
-
ASHBURN, Va., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announced the closing of its previously announced p...
-
ASHBURN, Va., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announced the pricing of its "reasonable best effor...